Company Encyclopedia
View More
name
Ameriprise Financial
AMP.US
Ameriprise Financial, Inc., together with its subsidiaries, operates as a diversified financial services company in the United States and internationally. The company offers financial planning and advice services to individual and institutional clients. It operates through Advice & Wealth Management, Asset Management, and Retirement & Protection Solutions segments. The Advice & Wealth Management segment provides financial planning and advice; brokerage products and services for retail and institutional clients; discretionary and non-discretionary investment advisory accounts; mutual funds; insurance and annuities products; cash management and banking products; and face-amount certificates.
1.124 T
AMP.USMarket value -Rank by Market Cap -/-

Financial Score

04/12/2025 Update
C
Asset Management and Custody BanksIndustry
Industry Ranking28/119
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE59.59%A
    • Profit Margin19.59%A
    • Gross Margin56.73%B
  • Growth ScoreB
    • Revenue YoY6.12%C
    • Net Profit YoY33.95%B
    • Total Assets YoY2.21%C
    • Net Assets YoY12.95%B
  • Cash ScoreC
    • Cash Flow Margin510.56%C
    • OCF YoY6.12%C
  • Operating ScoreE
    • Turnover0.1E
  • Debt ScoreE
    • Gearing Ratio96.60%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    REG - Phoenix SpreeDeutsch - Holding(s) in Company

    Phoenix Spree Deutschland Limited announced a change in major holdings, with Ameriprise Financial, Inc. acquiring or disposing of voting rights. The threshold was crossed on December 1, 2025, with Ameriprise holding 19.86% of voting rights. The notification was completed on December 4, 2025, in Swindon, UK.

    London Stock Exchange·
    US
    AMP
    +0.85%
    London Stock Exchange·
    US
    AMP
    +0.85%

    Ameriprise Financial Inc. Stock Outperforms Competitors On Strong Trading Day

    Ameriprise Financial Inc. shares rose 2.92% to $470.11, outperforming competitors like Morgan Stanley and Bank of New York Mellon Corp. during a strong trading session. The stock is 19.23% below its 52-week high. Trading volume exceeded its 50-day average.

    Dow Jones·
    US
    AMP
    +0.85%
    Dow Jones·
    US
    AMP
    +0.85%

    Is Ameriprise Financial Stock Underperforming the S&P 500?

    Is Ameriprise Financial Stock Underperforming the S&P 500?

    Barchart Option·
    US
    AMP
    +0.85%
    Barchart Option·
    US
    AMP
    +0.85%

    Advisor Joins Ameriprise Financial With $110 Million In Assets for Financial Planning Culture and Growth Opportunities

    Financial advisor Mike Felton, CFP®, has joined Ameriprise Financial from Merrill Lynch, bringing $110 million in client assets. Felton chose Ameriprise for its comprehensive financial planning culture, integrated support model, and advanced technology, aiming for greater control over his practice and enhanced client relationships. This move highlights Ameriprise's continued success in attracting experienced advisors.

    Business Wire·
    US
    AMP
    +0.85%
    Business Wire·
    US
    AMP
    +0.85%

    Black Forest Labs Says $300 Million Series B Led By AMP And Salesforce Ventures, At Valuation Of $3.25 Billion

    BLACK FOREST LABS: ANNOUNCES $300 MILLION SERIES B LED BY AMP AND SALESFORCE VENTURES, AT A POST-MONEY VALUATION OF $3.25 BILLION

    Reuters·
    US
    CRM
    +3.66%
    US
    AMP
    +0.85%
    Reuters·
    US
    CRM
    +3.66%
    US
    AMP
    +0.85%
    Posts
    View More

    Recursion Pharmaceuticals (RXRX) $Recursion Pharmaceuticals(RXRX.US) In-depth Research Report: From Phenotypic Screening to Vertical Integration—Revaluation After Exscientia Acquisition and the New Pa......

    • 0
    © 2025 Longbridge｜Disclaimer